Clinical Trials

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT07281430 2026-02-17

LMI-001-A-S04

Phase NA Recruiting

500 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07281599 2026-02-02

EQUIP

Phase NA Recruiting

450 enrolled

Phase NA Active not recruiting

Genital Diseases, Uterine Cervical Neoplasms, Sexually Transmitted Diseases, Sexually Transmitted Diseases, Viral, Papillomavirus Infections

NCT06611540 2025-12-30

LMI-001-A-S03

500 enrolled

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2025-12-15

LMI-001-A-S02

500 enrolled

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT05074264 2025-11-10

CAMPO-101

1,586 enrolled

HIV Infections

NCT06165614 2025-08-19

Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya

Phase 1 Completed

17 enrolled

Phase NA Enrolling by invitation

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT05231993 2025-03-19

Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening

280 enrolled

Uterine Cervical Neoplasms

NCT03150745 2024-07-31

Diagnosis of Cervical Lesions in Women With Unhealthy Looking Cervix

Phase NA Withdrawn

Phase NA Not yet recruiting

Uterine Cervical Dysplasia

NCT06366516 2024-04-16

MTTRIHPW

10,000 enrolled

Phase 3 Active not recruiting

Squamous Intraepithelial Lesions, Adenocarcinoma in Situ

NCT04794660 2024-03-13

CESTA

1,500 enrolled

Papillomavirus Infections

NCT00250055 2024-03-12

Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue

Phase NA Terminated

100 enrolled

Tumor-Agnostic

Neoplasms

NCT01234480 2023-05-16

Intended Use Study of the BD SurePath Plus™ Pap

Terminated

5,859 enrolled 4 charts

Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Neoplasms, Squamous Cell

NCT02910388 2020-06-02

LLETZ Under Direct Colposcopic Vision

150 enrolled

Uterine Cervical Dysplasia

NCT04369339 2020-04-30

Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology

185 enrolled

Neoplasms, Papillomavirus Infections

NCT02067468 2019-09-19

ASCUS-COL

2,661 enrolled 18 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01131312 2018-11-20

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

Phase 3 Completed

5,060 enrolled 10 charts

Uterine Cervical Dysplasia

NCT01944722 2018-06-12

Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens

33,858 enrolled 25 charts

Uterine Cervical Neoplasms

NCT03466710 2018-05-02

Post Colposcopy Management of ASC-US and LSIL Pap Tests

133 enrolled

Uterine Cervical Neoplasms

NCT03020121 2018-01-31

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Phase NA Terminated

28 enrolled

Uterine Cervical Neoplasms

NCT00602368 2017-02-01

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia

114 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00629577 2017-02-01

SAGE

Phase 1 Terminated

50 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00529464 2016-05-09

Spectroscopy Versus Standard Care in Cervical Cancer Patients

Phase 3 Terminated

2 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01524003 2015-05-08

CHICAPS

8,382 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01313104 2012-06-11

Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer

Phase NA Withdrawn

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT00632190 2010-01-28

Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy

1,800 enrolled